Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

HLA-DQβ57, anti-insulin T cells and insulin mimicry in autoimmune diabetes

Arcadio Rubio García, Athina Paterou, Rebecca D. Powell Doherty, Laurie G. Landry, Mercede Lee, Amanda M. Anderson, Hubert Slawinski, View ORCID ProfileRicardo C. Ferreira, Dominik Trzupek, Agnieszka Szypowska, Linda S. Wicker, Luc Teyton, Nicola Ternette, Maki Nakayama, John A. Todd, Marcin L. Pekalski
doi: https://doi.org/10.1101/2022.05.11.22274678
Arcadio Rubio García
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: john.todd@well.ox.ac.uk arcadio.rubiogarcia@bnc.ox.ac.uk marcin.pekalski@paediatrics.ox.ac.uk
Athina Paterou
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca D. Powell Doherty
2The Jenner Institute, Centre for Immuno-Oncology, Old Road Campus Research Building, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurie G. Landry
4Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mercede Lee
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda M. Anderson
4Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hubert Slawinski
3Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo C. Ferreira
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo C. Ferreira
Dominik Trzupek
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnieszka Szypowska
7Department of Pediatrics, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda S. Wicker
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luc Teyton
8Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Ternette
2The Jenner Institute, Centre for Immuno-Oncology, Old Road Campus Research Building, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maki Nakayama
4Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA
5Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA
6Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John A. Todd
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: john.todd@well.ox.ac.uk arcadio.rubiogarcia@bnc.ox.ac.uk marcin.pekalski@paediatrics.ox.ac.uk
Marcin L. Pekalski
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
9Department of Paediatrics, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: john.todd@well.ox.ac.uk arcadio.rubiogarcia@bnc.ox.ac.uk marcin.pekalski@paediatrics.ox.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Type 1 diabetes (T1D) is caused by a T-cell-mediated destruction of insulin-secreting pancreatic islet β cells. The T1D-predisposing human leukocyte antigen (HLA) class II molecule, DQ8, binds and presents insulin B chain peptides in the thymus producing autoreactive CD4+ T cells1–12. Here, we show that this process is driven by negatively-charged T cell receptor (TCR) complementarity-determining region 3β (CDR3β) sequences interacting with alanine at position 57 of the DQ8 β chain. Since T1D aetiology is linked to gut microbiota dysbiosis13–18, we hypothesized that the commensal proteome contains mimics of the primary insulin B:9-23 epitope that control TCR selection and tolerance. We identified a large set of bacterial proteins with significant similarity to insulin B:9-25, particularly from the transketolase (TKT) superfamily. We isolated a CD4+ TCR with a negatively-charged CDR3β from the pancreas of a DQ8-positive patient that was cross-reactive with one of these TKT peptides and insulin B:9-23. The T1D-protective molecule, DQ6, with the negatively-charged aspartic acid (D) at DQβ57(12,19), showed strong TKT mimotope binding, supporting a role for TKT-specific regulatory T cells in resistance to T1D. We propose that in a DQ8+DQ6− child with a proinflammatory dysbiotic gut microbiota, cross-reactive TKT-insulin B chain peptide T effector cells escape from the thymus and initiate T1D. TKT is a strong candidate because it is highly upregulated during weaning, a key period in T1D aetiology, and hence a prominent target for an autoimmune-prone immune system. Inhibiting gut dysbiosis and improving immune tolerance to TKT and other mimotopes, especially before and during weaning, could be a route to primary prevention of T1D and other common diseases.

Competing Interest Statement

JAT is a member of a GSK Human Genetics Advisory Board

Funding Statement

This work has been supported by a JDRF (4-SRA-2017-473-A-N) and Wellcome (107212/A/15/Z) Strategic Award.

D-GAP was a centre grant funded by the JDRF (1-2007-1803).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

DGAP: Diabetes, Genes, Autoimmunity and Prevention: London Hampstead Research Committee of the NHS Health Research Authority gave ethical approval for this work; ethics reference number 08/H0720/25. Samples were transferred to ethics 08/H0308/153 Investigating Genes and Phenotypes of Type 1 Diabetes (Cambridgeshire 2 Research Ethics Committee) upon closure of the DGAP study.

DMech: Investigating underlying causal mechanisms in type 1 diabetes

South Central Oxford A Research Ethics committee of the NHS Health Research Authority gave ethical approval for this work; ethics reference number 18/SC/0559.

The Network for Pancreatic Organ donors with Diabetes (nPOD): studies involving human participants were reviewed and approved by the University of Florida Institutional Research Board (IRB201600029).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study will be available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 14, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
HLA-DQβ57, anti-insulin T cells and insulin mimicry in autoimmune diabetes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
HLA-DQβ57, anti-insulin T cells and insulin mimicry in autoimmune diabetes
Arcadio Rubio García, Athina Paterou, Rebecca D. Powell Doherty, Laurie G. Landry, Mercede Lee, Amanda M. Anderson, Hubert Slawinski, Ricardo C. Ferreira, Dominik Trzupek, Agnieszka Szypowska, Linda S. Wicker, Luc Teyton, Nicola Ternette, Maki Nakayama, John A. Todd, Marcin L. Pekalski
medRxiv 2022.05.11.22274678; doi: https://doi.org/10.1101/2022.05.11.22274678
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
HLA-DQβ57, anti-insulin T cells and insulin mimicry in autoimmune diabetes
Arcadio Rubio García, Athina Paterou, Rebecca D. Powell Doherty, Laurie G. Landry, Mercede Lee, Amanda M. Anderson, Hubert Slawinski, Ricardo C. Ferreira, Dominik Trzupek, Agnieszka Szypowska, Linda S. Wicker, Luc Teyton, Nicola Ternette, Maki Nakayama, John A. Todd, Marcin L. Pekalski
medRxiv 2022.05.11.22274678; doi: https://doi.org/10.1101/2022.05.11.22274678

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (415)
  • Anesthesia (90)
  • Cardiovascular Medicine (858)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8561)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1750)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1242)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10301)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (252)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1769)
  • Public and Global Health (3837)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)